Carestream Technology Deployed at Geisinger Health System
The Neuroscience Institute at Geisinger Health System is deploying the KODAK In-Vivo Multispectral Imaging System FX. This tool is one of the latest systems for optical molecular imaging technology. The facility is using the system to develop a new treatment approach for brain cancer.
The treatment under development requires high levels of precision to deliver fluorescent nanospheres to support visualization of of malignant lesions. Surgical approaches are frequently limited secondary to the inability to distinguish healthy and cancerous tissue intraoperatively.
The KODAK tool enables location and monitoring of molecular activity within specific organs and cells. It incorporates multispectral tuning of excitation light. This method improves the sensitivity and enhancement of images. Availability of such increases the opportunity to identify and separate different biologic marker signals. It further helps to eliminate background noise.
Treatment of brain tumors would benefit from the improved imaging. Specifically, the technology of the Carestream tool supports precision in the placement of needles used to biopsy sites of disease. If the research is successful, clinicians may be better able to treat brain tumors by resecting entire tumors. This should decrease complications and, ultimately, increase the overall rate of disease survival.
June 27, 2008 Related topics: New Technology & Innovation, Imaging, Contract Awards, Diagnostic, Psychiatry & Neurology